JosephMelnik (Joe)

Partner

Silicon Valley + 1.650.687.4151

Joe Melnik's practice is focused on technology licensing, technology commercialization, and other technology-related transactions. Joe counsels clients on complex transactions related to a broad range of technologies including software, semiconductors, energy, data and network security, and consumer devices. He negotiates and structures license agreements, joint ventures, joint development agreements, strategic alliances, services, supply, and various other agreements for domestic and global projects. Joe also advises companies of all sizes on the development and implementation of strategies for maximizing the benefits of technology transactions; advising on intellectual property issues that arise in connection with corporate transactions, such as mergers and acquisitions; and assisting clients in developing domestic and international product commercialization strategies that utilize intellectual property positions to protect and expand market share.

Joe also represents clients in patent litigation, license disputes, and post-grant proceedings. He has successfully represented companies in patent cases relating to a wide variety of technologies, including cryptography, smart cards, biometrics, cellular telephony, SMS, computer networking, wireless communications, semiconductors, database technologies, and financial transactions. In addition, he frequently represents companies in high-stakes licensing disputes in a broad range of technology areas and has been lead counsel on numerous IPR proceedings before the Patent Trial and Appeal Board.

Joe's practice further includes the development and management of patent portfolios, freedom-to-practice opinions, and strategic counseling. In this role, he counsels clients developing robust intellectual property portfolios, mining portfolios for key assets, and managing a company's intellectual capital to maximize commercial benefits while minimizing risks and costs.

Experience

  • Playboy to become public company by combining with Mountain Crest Acquisition Corp.Jones Day is advising Playboy Enterprises, Inc. in its definitive merger agreement with Mountain Crest Acquisition Corp. (Nasdaq: MCAC) ("Mountain Crest"), a publicly-traded special purpose acquisition corporation (SPAC), whereby Playboy shareholders will be entitled to receive shares of common stock in Mountain Crest, and Mountain Crest will assume outstanding Playboy debt, for a total purchase price valued at approximately $381 million.
  • DataBank to acquire zColoJones Day is advising DataBank, a leading provider of enterprise-class colocation, connectivity, and managed services, on its acquisition of zColo, including certain U.S. and European data center assets, from Zayo Group Holdings, Inc.
  • RotaDyne sold Elastomer Processing Group rubber manufacturing business to Ace Midwest, LLCJones Day advised Rotation Dynamics Corporation d/b/a RotaDyne in its sale of substantially all of the operating assets of the Elastomer Processing Group rubber manufacturing business, and certain real property located in Chicago, Illinois, to Ace Midwest, LLC, a subsidiary of Ace Elastomer, Inc.
  • RotaDyne sold roller business assets to Finzer Roller, Inc.Jones Day advised Rotation Dynamics Corporation d/b/a RotaDyne in its sale of substantially all of its roller business assets to Finzer Roller, Inc.
  • SunPower closes sponsored spin-off of solar panel production operationsJones Day advised SunPower Corporation (NASDAQ: SPWR), one of North America's largest solar-panel makers, in a sponsored spin-off of its solar panel production operations into a new public company – Maxeon Solar Technologies – which will be headquartered in Singapore.
  • Sequential Technology International sold to APC HoldingsJones Day advised Sequential Technology International LLC, an innovative leader in the software, consulting, and BPO sectors, in its sale to APC Holdings.
  • NVIDIA acquires Mellanox Technologies for approximately $7 billionJones Day advised NVIDIA Corporation in its acquisition of Mellanox Technologies, Ltd., an Israel-based leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage.
  • Telemedicine provider expands telehealth programming in response to COVID-19 public health crisisJones Day represented a telemedicine provider in their expansion of telehealth programming in response to the COVID-19 public health crisis.
  • Synaptics divests LCD TDDI business to Hua Capital for $139.4 millionJones Day advised Synaptics Incorporated in its $139.4 million divestiture of its Asia-based mobile LCD TDDI Business to an affiliate of Hua Capital.
  • Hitachi Vantara acquires Waterline Data, Inc.Jones Day advised Hitachi Vantara LLC, a wholly owned subsidiary of Hitachi, Ltd., in its acquisition of all of the assets of Waterline Data, Inc., a U.S.-based company that provides intelligent data cataloging solutions for DataOps that help customers more easily gain actionable insights from large datasets and comply with data regulations.
  • Western Digital sells ActiveScale™ business to QuantumJones Day advised Western Digital Corporation's subsidiary Western Digital Technologies, Inc. in the sale of its ActiveScale™ business to Quantum Corporation.
  • Hitachi Vantara acquires ContainerShip, Inc.Jones Day advised Hitachi Vantara LLC in its acquisition of assets from ContainerShip, Inc., a start-up company specializing in the Kubernetes open-source platform space.
  • Resonant Therapeutics enters into strategic alliance with Retrogenix to identify targets of anti-tumor antibodiesJones Day represented Resonant Therapeutics, Inc. in a strategic alliance with Retrogenix to identify the targets of Resonant antibodies directed against the tumor microenvironment.
  • Resonant Therapeutics enters into target discovery and therapeutic validation collaboration agreement with JanssenJones Day represented Resonant Therapeutics, Inc. in an agreement with Janssen Research and Development, LLC with the aim to discover and validate novel tumor and immunological targets and to validate certain therapeutic candidates.
  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • Western Digital sells IntelliFlash™ business to DataDirect Networks, Inc. (DDN®)Jones Day advised Western Digital Corp. in the sale of its IntelliFlash™ business to DataDirect Networks, Inc. (DDN®), a global leader in artificial intelligence (AI) and multi-cloud data management.
  • Modern Media Acquisition completes merger agreement with Akazoo Ltd.Jones Day advised Modern Media Acquisition Corp. ("MMDM"), a special purpose acquisition company, in its business combination with Akazoo Limited, a U.K.- based digital music streaming platform specializing in emerging markets.
  • Educational Testing Service invests $2 million into LearnLaunch-operated, ETS-sponsored accelerator for education start-upsJones Day advised Educational Testing Service in its $2 million investment into a LearnLaunch-operated, ETS-sponsored accelerator for education start-ups.
  • Evidera acquires MedimixJones Day advised Evidera, a business unit of Pharmaceutical Product Development, LLC, in its acquisition of Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic, and medical device industries.
  • Drive.ai sold to Apple Inc.Jones Day advised Drive.ai in the sale of substantially all of its assets to Apple Inc.
  • Speaking Engagements

    • December 3, 2009
      Intellectual Property at Home and Abroad
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.